These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10376077)

  • 1. Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler-Najjar syndrome.
    Ihara H; Hashizume N; Shimizu N; Aoki T
    Ann Clin Biochem; 1999 May; 36 ( Pt 3)():347-52. PubMed ID: 10376077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in plasma retinol in unconjugated hyperbilirubinemia treated with bilirubin adsorption using an anion-exchange resin.
    Ihara H; Shino Y; Hashizume N; Aoki T; Suzuki Y; Igarasi Y; Naito C
    J Nutr Sci Vitaminol (Tokyo); 1998 Apr; 44(2):329-36. PubMed ID: 9675713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of three methods evaluating the saturation of serum bilirubin transporters in children with type I Crigler Najjar disease].
    Francoual J; Myara A; Trivin F; Leluc R; Odièvre M
    Arch Fr Pediatr; 1990 Dec; 47(10):721-3. PubMed ID: 2082845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.
    Strauss KA; Ahlfors CE; Soltys K; Mazareigos GV; Young M; Bowser LE; Fox MD; Squires JE; McKiernan P; Brigatti KW; Puffenberger EG; Carson VJ; Vreman HJ
    Hepatology; 2020 Jun; 71(6):1923-1939. PubMed ID: 31553814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis.
    Sinaasappel M; Jansen PL
    Gastroenterology; 1991 Mar; 100(3):783-9. PubMed ID: 1993500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of protein-bound and unbound unconjugated bilirubin by perfusion of plasma through an anion-exchange resin in a case of Crigler-Najjar syndrome type I.
    Ihara H; Shino Y; Hashizume N; Shimizu N; Aoki T; Yoshida M
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):528-33. PubMed ID: 14503990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Crigler-Najjar syndrome type I: long survival with bilirubin adsorption and liver transplantation].
    Shimizu N; Mizutani M; Aoki T
    No To Hattatsu; 2005 Jul; 37(4):337-41. PubMed ID: 16026101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness to phenobarbital in an adult with Crigler-Najjar disease associated with neurological involvement and skin hyperextensibility.
    Persico M; Romano M; Muraca M; Gentile S
    Hepatology; 1991 Feb; 13(2):213-5. PubMed ID: 1899849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of deafness in Crigler-Najjar syndrome type 1: a patient survey.
    Suresh G; Lucey JF
    Pediatrics; 1997 Nov; 100(5):E9. PubMed ID: 9347003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple plasma exchanges successfully maintain a young adult patient with Crigler-Najjar syndrome type I.
    Ahmed P; Pratt A; Land VJ; Flye MW; Chaplin H
    J Clin Apher; 1989; 5(1):17-20. PubMed ID: 2777735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy in Patients with the Crigler-Najjar Syndrome.
    D'Antiga L; Beuers U; Ronzitti G; Brunetti-Pierri N; Baumann U; Di Giorgio A; Aronson S; Hubert A; Romano R; Junge N; Bosma P; Bortolussi G; Muro AF; Soumoudronga RF; Veron P; Collaud F; Knuchel-Legendre N; Labrune P; Mingozzi F
    N Engl J Med; 2023 Aug; 389(7):620-631. PubMed ID: 37585628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crigler-Najjar Type 1 syndrome: absence of hepatic bilirubin UDP-glucuronyl transferase activity and therapeutic responses to light.
    Farrell GC; Gollan JL; Stevens SM; Grierson JM
    Aust N Z J Med; 1982 Aug; 12(4):280-5. PubMed ID: 6814411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of bilirubin to serum albumin in Crigler-Najjar syndrome, type I].
    Ihara H; Aoki Y; Aoki T; Toyoda M
    Rinsho Byori; 1986 Sep; 34(9):1075-8. PubMed ID: 3795542
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilirubin photoisomerization products in serum and urine from a Crigler-Najjar type I patient treated by phototherapy.
    Agati G; Fusi F; Pratesi S; Galvan P; Donzelli GP
    J Photochem Photobiol B; 1998 Dec; 47(2-3):181-9. PubMed ID: 10093917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological follow-up of two siblings with Crigler-Najjar syndrome type I and review of literature.
    Bayram E; Öztürk Y; Hız S; Topçu Y; Kılıç M; Zeytunlu M
    Turk J Pediatr; 2013; 55(3):349-53. PubMed ID: 24217087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free bilirubin measurements in a patient with Crigler-Najjar syndrome after crush injury.
    Mooney RA; Smith CH; Zarkowsky HS
    J Pediatr; 1983 Aug; 103(2):262-5. PubMed ID: 6875720
    [No Abstract]   [Full Text] [Related]  

  • 17. The anesthetic implications of Crigler-Najjar syndrome.
    Robards C; Brull SJ
    Anesth Analg; 2007 Feb; 104(2):435-6. PubMed ID: 17242105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease.
    Strauss KA; Robinson DL; Vreman HJ; Puffenberger EG; Hart G; Morton DH
    Eur J Pediatr; 2006 May; 165(5):306-19. PubMed ID: 16435131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate treatment in two adults with Crigler-Najjar syndrome type II.
    Yilmaz S; Dursun M; Canoruç F; Kidir V; Beştaş R
    Turk J Gastroenterol; 2006 Mar; 17(1):62-5. PubMed ID: 16830281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living related liver transplantation in Crigler-Najjar syndrome type 1.
    Ozçay F; Alehan F; Sevmiş S; Karakayali H; Moray G; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2875-7. PubMed ID: 19765461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.